GGrantIndex
← Leaderboards

Brent E Palmer

University Of Colorado Denver

$8,372,659
Attributed
$16,741,385
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200825
$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,741,385 · 9

By mechanism

R01$12,611,454 · 6
U01$3,368,661 · 1
R21$662,574 · 1
F32$98,696 · 1

Top collaborators

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsChronicImmuneT-LymphocytePhenotypeLeadInflammatoryLinkAntiretroviral TherapyCd4 Positive T LymphocytesResponseDietCytokineAdaptive ImmunityInfectionHiv SeropositivityImmune ResponseInterleukin-10Anti-InflammatoryInflammationLungAntigensBacteriaBlood

Grant awards (34)

Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men$690,739
R01 · FY2025 · DK
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men$663,109
R01 · FY2024 · DK
T cell Epitope Discovery in Sarcoidosis$554,776
R01 · FY2024 · HL · contact PI
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men$690,739
R01 · FY2023 · DK
T cell Epitope Discovery in Sarcoidosis$566,098
R01 · FY2023 · HL · contact PI
Gut microbiome effects on intestinal barrier function and metabolic syndrome in HIV positive men who have sex with men$690,739
R01 · FY2022 · DK
Role of Chemokines in Innate and Adaptive Immunity in the Lung$602,292
R01 · FY2022 · HL · contact PI
T cell Epitope Discovery in Sarcoidosis$566,098
R01 · FY2022 · HL · contact PI
T cell Epitope Discovery in Sarcoidosis$613,610
R01 · FY2021 · HL · contact PI
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response$469,489
R01 · FY2020 · HL · contact PI
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$600,187
R01 · FY2019 · DK · contact PI
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response$469,489
R01 · FY2019 · HL · contact PI
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$600,188
R01 · FY2018 · DK · contact PI
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response$469,489
R01 · FY2018 · HL · contact PI
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$388,750
R01 · FY2018 · DK
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung disease$684,200
U01 · FY2017 · HL
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$599,064
R01 · FY2017 · DK · contact PI
HIV-associated gut microbiome affects lung immunity and pneumococcal immune response$469,489
R01 · FY2017 · HL · contact PI
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$388,750
R01 · FY2017 · DK
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung disease$684,200
U01 · FY2016 · HL
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$599,063
R01 · FY2016 · DK · contact PI
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$388,750
R01 · FY2016 · DK
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung disease$684,200
U01 · FY2015 · HL
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV Patients$600,187
R01 · FY2015 · DK · contact PI
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$388,750
R01 · FY2015 · DK
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$153,901
R01 · FY2015 · DK
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung disease$668,539
U01 · FY2014 · HL
Factors mediating gut microbiota dysbiosis and metabolic disease in HIV patients$387,708
R01 · FY2014 · DK
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung disease$647,522
U01 · FY2013 · HL
Enhancement of HIV-specific CD4+ T cell function by blockade of the PD-1 pathway$229,875
R21 · FY2009 · AI · contact PI
Enhancement of HIV-specific CD4+ T cell function by blockade of the PD-1 pathway$228,512
R21 · FY2009 · AI · contact PI
Enhancement of HIV-specific CD4+ T cell function by blockade of the PD-1 pathway$204,187
R21 · FY2008 · AI · contact PI
Mechanisms of HIV-1-Specific CD4+ T Cell Dysfunction$50,548
F32 · FY2004 · AI
Mechanisms of HIV-1-Specific CD4+ T Cell Dysfunction$48,148
F32 · FY2003 · AI